Adar1 capital management increases stake in Keros Therapeutics with $328k purchase

Adar1 capital management increases stake in Keros Therapeutics with $328k purchase#Adar1 #capital #management #increases #stake #Keros…

Adar1 partners increases stake in Keros Therapeutics with $9.1m purchase

Adar1 partners increases stake in Keros Therapeutics with $9.1m purchase#Adar1 #partners #increases #stake #Keros #Therapeutics #9.1m…

Keros Therapeutics: A Biotech Stock on the Move Amid Strategic Review and Rights Plan

In a move that’s got investors buzzing, Keros Therapeutics (NASDAQ: KROS) has announced a review of…